A citation-based method for searching scientific literature

Maria Concetta Fargnoli, Sara Gandini, Ketty Peris, Patrick Maisonneuve, Sara Raimondi. Eur J Cancer 2010
Times Cited: 58







List of co-cited articles
613 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Alisa M Goldstein, May Chan, Mark Harland, Nicholas K Hayward, Florence Demenais, D Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi-Scarra, William Bruno,[...]. J Med Genet 2007
260
41

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Satoru Yokoyama, Susan L Woods, Glen M Boyle, Lauren G Aoude, Stuart MacGregor, Victoria Zismann, Michael Gartside, Anne E Cust, Rizwan Haq, Mark Harland,[...]. Nature 2011
283
36

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d'Hayer, Hamida Mohamdi, Audrey Remenieras,[...]. Nature 2011
331
32

MC1R variants, melanoma and red hair color phenotype: a meta-analysis.
Sara Raimondi, Francesco Sera, Sara Gandini, Simona Iodice, Saverio Caini, Patrick Maisonneuve, Maria Concetta Fargnoli. Int J Cancer 2008
233
31

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Alisa M Goldstein, May Chan, Mark Harland, Elizabeth M Gillanders, Nicholas K Hayward, Marie-Francoise Avril, Esther Azizi, Giovanna Bianchi-Scarra, D Timothy Bishop, Brigitte Bressac-de Paillerets,[...]. Cancer Res 2006
280
29

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
L Zuo, J Weger, Q Yang, A M Goldstein, M A Tucker, G J Walker, N Hayward, N C Dracopoli. Nat Genet 1996
613
29

MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.
N F Box, D L Duffy, W Chen, M Stark, N G Martin, R A Sturm, N K Hayward. Am J Hum Genet 2001
220
25

Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002
339
25

Melanocortin 1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden.
Patricia F Williams, Catherine M Olsen, Nicholas K Hayward, David C Whiteman. Int J Cancer 2011
87
25

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
25

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Hanne Eknes Puntervoll, Xiaohong R Yang, Hildegunn Høberg Vetti, Ingeborg M Bachmann, Marie Françoise Avril, Meriem Benfodda, Caterina Catricalà, Stéphane Dalle, Anne B Duval-Modeste, Paola Ghiorzo,[...]. J Med Genet 2013
79
25

Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?
J S Palmer, D L Duffy, N F Box, J F Aitken, L E O'Gorman, A C Green, N K Hayward, N G Martin, R A Sturm. Am J Hum Genet 2000
386
24

Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Damiano Abeni, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
492
24

Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Roberto Zanetti, Cinzia Masini, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
444
24

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
203
24

Germline p16 mutations in familial melanoma.
C J Hussussian, J P Struewing, A M Goldstein, P A Higgins, D S Ally, M D Sheahan, W H Clark, M A Tucker, N C Dracopoli. Nat Genet 1994
22

Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
Peter A Kanetsky, Saarene Panossian, David E Elder, DuPont Guerry, Michael E Ming, Lynn Schuchter, Timothy R Rebbeck. Cancer 2010
74
20

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
F Demenais, H Mohamdi, V Chaudru, A M Goldstein, J A Newton Bishop, D T Bishop, P A Kanetsky, N K Hayward, E Gillanders, D E Elder,[...]. J Natl Cancer Inst 2010
76
20

POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
224
20

Comprehensive evaluation of allele frequency differences of MC1R variants across populations.
Meg R Gerstenblith, Alisa M Goldstein, Maria Concetta Fargnoli, Ketty Peris, Maria Teresa Landi. Hum Mutat 2007
118
17

Role of the CDKN2A locus in patients with multiple primary melanomas.
Susana Puig, Josep Malvehy, Cèlia Badenas, Anna Ruiz, Dolores Jimenez, Francisco Cuellar, Antoni Azon, Urbá Gonzàlez, Teresa Castel, Antoni Campoy,[...]. J Clin Oncol 2005
106
17

Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Orietta Picconi, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
751
17

Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history.
P Ghiorzo, L Pastorino, P Queirolo, W Bruno, M G Tibiletti, S Nasti, V Andreotti, B Bressac-de Paillerets, G Bianchi Scarrà. Pigment Cell Melanoma Res 2013
65
17

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Lauren G Aoude, Antonia L Pritchard, Carla Daniela Robles-Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael Gartside, Víctor Quesada, Peter Johansson, Jane M Palmer,[...]. J Natl Cancer Inst 2014
104
17

Genetics of familial melanoma: 20 years after CDKN2A.
Lauren G Aoude, Karin A W Wadt, Antonia L Pritchard, Nicholas K Hayward. Pigment Cell Melanoma Res 2015
83
17

MC1R germline variants confer risk for BRAF-mutant melanoma.
Maria Teresa Landi, Jürgen Bauer, Ruth M Pfeiffer, David E Elder, Benjamin Hulley, Paola Minghetti, Donato Calista, Peter A Kanetsky, Daniel Pinkel, Boris C Bastian. Science 2006
238
15

Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Alisa M Goldstein, Maria Teresa Landi, Shirley Tsang, Mary C Fraser, David J Munroe, Margaret A Tucker. Cancer Epidemiol Biomarkers Prev 2005
80
15

Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles.
Kimberley A Beaumont, Sri N Shekar, Richard A Newton, Michael R James, Jennifer L Stow, David L Duffy, Richard A Sturm. Hum Mol Genet 2007
127
15

Genome-wide association study identifies three loci associated with melanoma risk.
D Timothy Bishop, Florence Demenais, Mark M Iles, Mark Harland, John C Taylor, Eve Corda, Juliette Randerson-Moor, Joanne F Aitken, Marie-Francoise Avril, Esther Azizi,[...]. Nat Genet 2009
335
15

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
15

Selection criteria for genetic assessment of patients with familial melanoma.
Sancy A Leachman, John Carucci, Wendy Kohlmann, Kimberly C Banks, Maryam M Asgari, Wilma Bergman, Giovanna Bianchi-Scarrà, Teresa Brentnall, Brigitte Bressac-de Paillerets, William Bruno,[...]. J Am Acad Dermatol 2009
109
15


Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
467
15

MITF: master regulator of melanocyte development and melanoma oncogene.
Carmit Levy, Mehdi Khaled, David E Fisher. Trends Mol Med 2006
718
13

MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters.
Veronica Höiom, Rainer Tuominen, Max Käller, Diana Lindén, Afshin Ahmadian, Eva Månsson-Brahme, Suzanne Egyhazi, Klas Sjöberg, Joakim Lundeberg, Johan Hansson. Pigment Cell Melanoma Res 2009
31
25

CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
L Pastorino, L Bonelli, P Ghiorzo, P Queirolo, L Battistuzzi, E Balleari, S Nasti, S Gargiulo, S Gliori, P Savoia,[...]. Pigment Cell Melanoma Res 2008
40
20

Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma.
P A van der Velden, L A Sandkuijl, W Bergman, S Pavel, L van Mourik, R R Frants, N A Gruis. Am J Hum Genet 2001
134
13

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
A Kamb, D Shattuck-Eidens, R Eeles, Q Liu, N A Gruis, W Ding, C Hussey, T Tran, Y Miki, J Weaver-Feldhaus. Nat Genet 1994
523
13

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Colin B Begg, Irene Orlow, Amanda J Hummer, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Stephen B Gruber, Hoda Anton-Culver, Roberto Zanetti,[...]. J Natl Cancer Inst 2005
146
13

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
N Soufir, M F Avril, A Chompret, F Demenais, J Bombled, A Spatz, D Stoppa-Lyonnet, J Bénard, B Bressac-de Paillerets. Hum Mol Genet 1998
309
13

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Ching-Ni Jenny Njauw, Ivana Kim, Adriano Piris, Michele Gabree, Michael Taylor, Anne Marie Lane, Margaret M DeAngelis, Evangelos Gragoudas, Lyn M Duncan, Hensin Tsao. PLoS One 2012
171
13

MC1R is a potent regulator of PTEN after UV exposure in melanocytes.
Juxiang Cao, Lixin Wan, Elke Hacker, Xiangpeng Dai, Stefania Lenna, Celia Jimenez-Cervantes, Yongjun Wang, Nick R Leslie, George X Xu, Hans R Widlund,[...]. Mol Cell 2013
98
13

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
Hildur Helgadottir, Veronica Höiom, Göran Jönsson, Rainer Tuominen, Christian Ingvar, Ake Borg, Håkan Olsson, Johan Hansson. J Med Genet 2014
50
16

MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.
Elena Pasquali, José C García-Borrón, Maria Concetta Fargnoli, Sara Gandini, Patrick Maisonneuve, Vincenzo Bagnardi, Claudia Specchia, Fan Liu, Manfred Kayser, Tamar Nijsten,[...]. Int J Cancer 2015
64
13

Melanoma genetics.
Jazlyn Read, Karin A W Wadt, Nicholas K Hayward. J Med Genet 2016
118
13

MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Maria Teresa Landi, Peter A Kanetsky, Shirley Tsang, Bert Gold, David Munroe, Timothy Rebbeck, Jennifer Swoyer, Monica Ter-Minassian, Mohammad Hedayati, Lawrence Grossman,[...]. J Natl Cancer Inst 2005
134
12

ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.
Daniel F Gudbjartsson, Patrick Sulem, Simon N Stacey, Alisa M Goldstein, Thorunn Rafnar, Bardur Sigurgeirsson, Kristrun R Benediktsdottir, Kristin Thorisdottir, Rafn Ragnarsson, Steinunn G Sveinsdottir,[...]. Nat Genet 2008
237
12

Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
Alisa M Goldstein, Valerie Chaudru, Paola Ghiorzo, Celia Badenas, Josep Malvehy, Lorenza Pastorino, Karine Laud, Benjamin Hulley, Marie-Francoise Avril, Joan A Puig-Butille,[...]. Int J Cancer 2007
40
17

MC1R variants increase risk of melanomas harboring BRAF mutations.
Maria Concetta Fargnoli, Kris Pike, Ruth M Pfeiffer, Shirley Tsang, Ester Rozenblum, David J Munroe, Yelena Golubeva, Donato Calista, Stefania Seidenari, Daniela Massi,[...]. J Invest Dermatol 2008
66
12

Somatic activation of KIT in distinct subtypes of melanoma.
John A Curtin, Klaus Busam, Daniel Pinkel, Boris C Bastian. J Clin Oncol 2006
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.